OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
14/05/2026
Voltar para busca
Dado oficial do USPTO
ROHTO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
15/05/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
3, 5
Data de depósito
10/06/2024
Data de registro
10/02/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/02/2026
Última transação
15/05/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
03
Localização do titular
JP
Examinador
CONNERS,LAUREN G
Unidade examinadora
O30
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the stylized word "ROHTO" with a curved line underneath emanating from the bottom of the letter "R", with a brief separation below the first letter "O", and ending at the second letter "O".
Titulares e representantes
Titulares
Rohto Pharmaceutical Co., Ltd.
Representantes
Kathleen S. Ryan The Ollila Law Group LLC
Classificação técnica
Classes Nice
Classe 3Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 3
Antistatic preparations for household purposes; de-greasing preparations for household purposes; rust removing preparations; stain removing benzine; fabric softeners for laundry use; laundry bleach; adhesives for affixing false hair; laundry starch; seaweed gelatine for laundry use (funori); adhesives for affixing false eyelashes; breath freshening preparations for personal hygiene; deodorants for animals; paint stripping preparations; shoe cream; shoe black being shoe polish; nonmedicated soaps and detergents for household use; dentifrices; cosmetics; perfumes and flavourings for beverages being essential oils; perfumes and food flavourings being essential oils; incense; false nails; false eyelashes
Classe 5
Pharmaceutical preparations being ophthalmological preparations; pharmaceutical preparations for treatment of cataracts; pharmaceutical preparations for treatment of glaucoma; pharmaceutical preparations for treatment of ocular hypertension; ophthalmic ointments for treatment of eye disease; pharmaceutical preparations for use in eye injections; pharmaceutical preparations for treatment of pinguecula ; pharmaceutical preparations for treatment of chalazion; pharmaceutical preparations for treatment of uveitis; eye drops for treatment of keratoconjunctival epithelial disorder; antibacterial eye drops; antiallergic eye drops; pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; Analgesics; antipyretic preparations; antibiotics; athletes' foot preparations; medicinal drinks; medicinal hair growth preparations; motion sickness treatment preparations; pharmaceutical preparations for treating diabetes; preparations for treating colds; pharmaceutical preparationsastringentsanti-inflammatory liquid for external usehypnotic sedativesantipyretic analgesicsanti-cough dropsvitamin preparations; reagent paper for medical purposes; oiled paper for medical purposes; adhesive tapes for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; liquid bandages for skin wounds; breast-nursing pads; cotton swabs for medical use; dental impression materials; baby diapers; adult diapers; baby diaper covers; adult diaper covers; fly catching paper; mothproofing paper; lacteal flour for babies; dietary supplements for human beings; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies; food for babies; dietary supplements for animals; semen for artificial insemination; stem cells for medicalpharmaceutical or veterinary use; stem cells for regenerative medicinemedicine or veterinary use; stem cells only for medical and veterinary use; diagnostic reagents for medical clinic or medical laboratory use; diagnostic media for bacteriological cultures for medical purposes or veterinary purposes; microorganism culture media for cultivating human cellshuman tissuesanimal cellsanimal tissuesplant cellsplant tissues and microorganism cellsfor medical use; cell culture media for medical or veterinary use; pharmaceutical serums made from blood for medical or veterinary use for promoting tissue regeneration and stimulating cell proliferation; pharmaceutical serums made from blood for medical or veterinary use for inducing cell repair; pharmaceutical serums made from blood for medical or veterinary use in regenerative medicine; pharmaceutical serums made from blood for medical or veterinary use in regenerative medicine for promoting tissue regenerationstimulating cell proliferationinducing cell repair; serums made from blood for diagnostic purposes; immunological serums made from blood for medical treatment of cartilage defectsskin woundsinternal organ diseases; serum made from blood for cell culture; pharmaceutical preparations comprising blood-derived antibodies for use in serotherapy; fumigants only for agricultural purposes; fungicides only for agricultural purposes; rodenticides only for agricultural purposes; insecticides only for agricultural purposes; herbicides being weedkillers; insect-repellents only for agricultural purposes; antiseptics only for agricultural purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/05/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/04/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
27/04/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/02/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
10/02/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/12/2025
PUBO
PUBLISHED FOR OPPOSITION
23/12/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17/12/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
26/11/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
25/11/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
25/11/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
25/11/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
25/11/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
27/10/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
27/10/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
27/10/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
27/10/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/09/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/09/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/09/2025
RFNT
REFUSAL PROCESSED BY IB
29/03/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/03/2025
RFRR
REFUSAL PROCESSED BY MPU
12/03/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
30/01/2025
CNRT
NON-FINAL ACTION WRITTEN
29/01/2025
DOCK
ASSIGNED TO EXAMINER
17/12/2024
MAFR
APPLICATION FILING RECEIPT MAILED
11/12/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/12/2024
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
11/12/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
28/11/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ROHTO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.